Picture of Corline Biomedical AB logo

CLBIO — Corline Biomedical AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapSucker Stock

Brief: Corline Biomedical Renegotiates Deal With Imperative Care

Nov 20 (Reuters) - Corline Biomedical AB  CLBIO.ST :
    * RENEGOTIATES AGREEMENT WITH IMPERATIVE CARE TO BROADEN CUSTOMER REACH IN NEUROVASCULAR
CHS™
APPLICATIONS
    * BELIEVES THAT THE POTENTIAL FOR CHS™ IN NEUROVASCULAR FIELD AMOUNTS TO AT LEAST SEK 150
MILLION
IN ANNUAL REVENUE

Source text:  ID:nGNE7FdbfR 
Further company coverage:  CLBIO.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

Recent news on Corline Biomedical AB

See all news